Skip to main content
. 2013 Nov 15;44(1):17–26. doi: 10.3892/ijo.2013.2179

Figure 2.

Figure 2.

Kaplan-Meier survival estimate. (A) Second line treatment, triplet chemotherapy plus targeted agent versus other medical and surgical treatments. (B) Second line treatment, triplet chemotherapy plus targeted agent versus triplet regimens. (1) Progression-free survival; (2) Overall survival.